Last reviewed · How we verify

Calcipotriol BDP gel — Competitive Intelligence Brief

Calcipotriol BDP gel (Calcipotriol BDP gel) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D3 analog / Corticosteroid combination. Area: Dermatology.

phase 3 Vitamin D3 analog / Corticosteroid combination Vitamin D receptor (VDR); Glucocorticoid receptor Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Calcipotriol BDP gel (Calcipotriol BDP gel) — LEO Pharma. Calcipotriol is a vitamin D3 analog that binds to the vitamin D receptor to regulate skin cell differentiation and reduce inflammation in psoriasis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Calcipotriol BDP gel TARGET Calcipotriol BDP gel LEO Pharma phase 3 Vitamin D3 analog / Corticosteroid combination Vitamin D receptor (VDR); Glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D3 analog / Corticosteroid combination class)

  1. LEO Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcipotriol BDP gel — Competitive Intelligence Brief. https://druglandscape.com/ci/calcipotriol-bdp-gel. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: